Specific interactions between human integrin α(v)β3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus

Virology

Volumn 239, Issue 1, 1997, Pages 150-157

  Sharma, Amit ^a   Rao, Zihe ^a,b   Fry, Elizabeth ^a   Booth, Timothy ^c   Jones, E Yvonne ^a,d   Rowlands, David J ^e   Simmons, David L ^f   Stuart, David I ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TSINGHUA UNIVERSITY   (China)

^c NATURAL ENVIRONMENT RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CHIMERIC PROTEIN; EPITOPE; FIBRONECTIN; HEPATITIS B CORE ANTIGEN; INTEGRIN; MANGANESE; VIRUS RECEPTOR; VITRONECTIN;

ANTIGEN BINDING; ARTICLE; FOOT AND MOUTH DISEASE VIRUS; HEPATITIS B VIRUS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRUS PARTICLE;

FOOT-AND-MOUTH DISEASE VIRUS; HEPATITIS B VIRUS;

EID: 0031454554     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8833     Document Type: Article

References (44)

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature. 337:1989;709-716.
2. Albelda S. M., Mette S. A., Elder D. E., Stewart R., Damjanovich L., Herlyn M., Buck C. A. Integrin distribution in malignant melanoma: Association of the beta-3 subunit with tumor progression. Cancer Res. 50:1990;6757-6764.
3. Baxt B., Mason P. W. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology. 207:1995;503-509.
4. Belin M. T., Boulanger P. Involvement of cellular adhesion sequences in the attachment of adenovirus to the HeLa cell surface. J. Gen. Virol. 74:1993;1485-1497.
5. Berinstein A., Roivainen M., Hovi T., Mason P. W., Baxt B. Antibodies to the vitronectin receptor (integrin alpha-v-beta-3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:1995;2664-2666.
6. Buckley C. D., Doyonnas R., Newton J. P., Blystone S. D., Brown E. J., Watt S. M., Simmons D. L. Identification of alpha-v-beta-3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109:1996;437-445.
7. Chambers M., Dougan G., Newman J., F B., Crowther J., Mould A. P., Humphries M. J., Francis M. J., Clarke B., Brown A. L., Rowlands D. Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions. J. Virol. 70:1996;4045-4052.
8. Coburn J., Leong J. M., Erban J. K. Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc. Natl. Acad. Sci. USA. 90:1993;7059-7063.
9. Defer C., Belin M. T., Caillet Boudin M. L., Boulanger P. Human adenovirus-host cell interactions: Comparative study with members of subgroups B and C. J. Virol. 64:1990;3661-3673.
10. Dransfield I., Cabanas C., Craig A., Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J. Cell Biol. 116:1992;219-226.
11. Fox G., Parry N. R., Barnett P. V., McGinn B., Rowlands D. J., Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70:1989;625-638.
12. Friedlander M., Brooks P. C., Shaffer R. W., Kincaid C. M., Varner J. A., Cheresh D. A. Definition of two angiogenic pathways by distinct alpha-v integrins. Science. 270:1995;1500-1502.
13. Gailit J., Ruoslahti E. Regulation of the fibronectin receptor affinity by divalent cations. J. Biol. Chem. 263:1988;12927-12932.
14. Geysen H. M., Barteling S. J., Meloen R. H. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. USA. 82:1985;178-182.
15. Giancotti F. G., Mainiero F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. Biophys. Acta. 1198:1994;47-64.
16. 2+. J. Biol. Chem. 270:1995;9917-9925.
17. Hughes P. A., Horsenell C., Hyypia T., Stanway G. The Coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 69:1995;8035-8040.
18. Hynes R. O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
19. Hyypia T., Horsnell C., Maaronen M., Khan M., Kalkkinen N., Auvinen P., Kinnunen L., Stanway G. A distinct picornavirus group identified by sequence analysis. Proc. Natl. Acad. Sci. USA. 89:1992;8847-8851.
20. Jackson T., Ellard F. M., Ghazaleh R. A., Brookes S. M., Blakemore W. E., Corteyn A. H., Stuart D. I., Newman J. W., King A. M. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:1996;5282-5287.
21. Jackson T., Sharma A., Ghazaleh R. A., Blakemore W. E., Ellard F. M., Simmons D. L., Stuart D. I., Newman J. W., King A. M. Arginine-glycine-aspartic acid specific binding by foot-and-mouth disease viruses to the purified integrin receptor, avb3,in vitro. J. Virol. 71:1997.
22. Kirchhofer D., Gailit J., Ruoslahti E., Grzesiak J., Pierschbacher M. D. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa. J. Biol. Chem. 265:1990;18525-18530.
23. Logan D., Abu Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature. 362:1993;566-568.
24. Maeda T., Oyama R., Ichihara Tanaka K., Kimizuka F., Kato I., Titani K., Sekiguchi K. A novel cell adhesive protein engineered by insertion of the Arg-Gly-Asp-Ser tetrapeptide. J. Biol. Chem. 264:1989;15165-15168.
25. Mason P. W., Baxt B., Brown F., Harber J., Murdin A., Wimmer E. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology. 192:1993;568-577.
26. Mason P. W., Rieder E., Baxt B. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA. 91:1994;1932-1936.
27. Montgomery A. M., Becker J. C., Siu C. H., Lemmon V. P., Cheresh D. A., Pancook J. D., Zhao X., Reisfeld R. A. Human neural cell adhesion molecular L1 and rat homologue NILE are ligands for integrin alpha-vbeta-3. J. Cell Biol. 132:1996;475-485.
28. Nemerow G. R., Cheresh D. A., Wickham T. J. Adenovirus entry into host cells: A role for alpha-v integrins. Trends Cell Biol. 4:1994;52-55.
29. Nermut M. V., Green N. M., Eason P., Yamada S. S., Yamada K. M. Electron microscopy and structural model of human fibronectin receptor. Embo J. 7:1988;4093-4099.
30. Pfaff M., Goehring W., Brown J. C., Timpl R. Binding of purified collagen receptors (alpha-1-beta-1, alpha-2-beta-1) and RGD-dependent integrins to laminins and laminin fragments. Eur. J. Biochem. 225:1994;975-984.
31. Piali L., Hammel P., Uherek C., Bachmann F., Gisler R. H., Dunon D., Imhof B. A. CD31/PECAM-1 is a ligand for alpha-v-beta-3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130:1995;451-460.
32. Pytela R., Pierschbacher M. D., Argraves S., Suzuki S., Ruoslahti E. Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol. 144:1987;475-489.
33. Rieder E., Baxt B., Lubroth J., Mason P. W. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J. Virol. 68:1994a;7092-7098.
34. Rieder E., Baxt B., Mason P. W. Animal-derived antigenic variants of foot-and-mouth disease virus type A-12 have low affinity for cells in culture. J. Virol. 68:1994b;5296-5299.
35. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypia T. Entry of coxsackievirus A9 into host cells: Specific interactions with alpha-v-beta-3 integrin, the vitronectin receptor. Virology. 203:1994;357-365.
36. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 238:1987;491-497.
37. Sekiguchi K., Franke A. J., Baxt B. Competition for cellular receptor sites among selected aphthoviruses. Arch. Virol. 74:1982;53-64.
38. Smith J. W., Cheresh D. A. The arginine-glycine-aspartic acid binding domain of the vitronectin receptor: Photoaffinity cross-linking implicates amino acid residues 61-203 of the beta subunit. J. Biol. Chem. 263:1988;18726-18731.
39. Smith J. W., Piotrowicz R. S., Mathis D. A mechanism for divalent cation regulation of beta-3-integrins. J. Biol. Chem. 269:1994;960-967.
40. Smith J. W., Tachias K., Madison E. L. Protein loop grafting to construct a variant of tissue-type plasminogen activator that binds platelet integrin alpha IIb beta 3. J. Biol. Chem. 270:1995;30486-30490.
41. Stanway G., Kalkkinen N., Roivainen M., Ghazi F., Khan M., Smyth M., Meurman O., Hyypia T. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J. Virol. 68:1994;8232-8238.
42. Suehiro K., Smith J. W., Plow E. F. The ligand recognition specificity of beta-3 integrins. J. Biol. Chem. 271:1996;10365-10371.
43. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
44. Yamada T., Song H., Inaka K., Shimada Y., Kikuchi M., Matsushima M. Structure of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme. J. Biol. Chem. 270:1995;5687-5690.